# data[].attributes.body
Nursing Interventions. Iggy pg 597

# data[].attributes.body
https://davisplus.fadavis.com/3976/meddeck/pdf/rifampin.pdf
-body secretions may have an orange discoloration
-may decrease effectiveness of oral contraceptives
-watch for signs and symptoms of hepatitis or of thromobocytopenia
-inform healthcare provider if flu-like symptoms develop
-may cause drowsiness
-avoid alcohol use during use of drug
-take all of the medication

# data[].attributes.body
Perform mycobacterial studies and susceptibility tests prior to and periodically
during therapy to detect possible resistance.
● Assess lung sounds and character and amount of sputum periodically during therapy.
● Lab Test Considerations: Evaluate renal function, CBC, and urinalysis periodically and during therapy.
● Monitor hepatic function at least monthly during therapy. May causeqBUN, AST,
ALT, and serum alkaline phosphatase, bilirubin, and uric acid concentrations.
● May cause false-positive direct Coombs’ test results. May interfere with folic acid
and vitamin B assays.
● May interfere with dexamethasone suppression test results; discontinue rifampin
15 days prior to test.
● May interfere with methods for determining serum folate and vitamin B levels and
with urine tests based on color reaction.
● May delay hepatic uptake and excretion of sulfobromophthalein (SBP) during
SBP uptake and excretion tests; perform test prior to daily dose of rifampin

# data[].attributes.body
https://davisplus.fadavis.com/3976/meddeck/pdf/rifampin.pdf

# data[].attributes.body
Advise patient to take medication once daily (unless biweekly regimens are used),
as directed, and not to skip doses or double up on missed doses. Emphasize the
importance of continuing therapy even after symptoms have subsided. Length of
therapy for tuberculosis depends on regimen being used and underlying disease
states. Patients on short-term prophylactic therapy should also be advised of the
importance of compliance with therapy.
● Advise patient to notify health care professional promptly if signs and symptoms of
hepatitis (yellow eyes and skin, nausea, vomiting, anorexia, unusual tiredness,
weakness) or of thrombocytopenia (unusual bleeding or bruising) occur.
● Caution patient to avoid the use of alcohol during this therapy, because this may
increase the risk of hepatotoxicity.
● Instruct patient to report the occurrence of flu-like symptoms (fever, chills, myal�gia, headache) promptly.
● Rifampin may occasionally cause drowsiness. Caution patient to avoid driving or
other activities requiring alertness until response to medication is known
Inform patient that saliva, sputum, sweat, tears, urine, and feces may become red�orange to red-brown and that soft contact lenses may become permanently discol�ored.
● Advise patient that this medication has teratogenic properties and may decrease
the effectiveness of oral contraceptives. Counsel patient to use a nonhormonal
form of contraception throughout therapy.
● Emphasize the importance of regular follow-up exams to monitor progress and to
check for side effects.

# data[].attributes.body
You’re welcome 😜

# data[].attributes.body
Another